In intervertebral disc degeneration, the HSP90 inhibitor 17-AAG attenuates the proinflammatory activity of M1 macrophages by inhibiting the p38 MAPK pathway. This evidence concerns the gene HSP90AB1 and Intervertebral disk degeneration.